Brain and gut interactions in irritable bowel syndrome: New paradigms and new understandings

Current Gastroenterology Reports

Volumn 16, Issue 4, 2014, Pages

  Coss Adame, Enrique ^c   Rao, Satish S C ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Section of Neurogastroenterology and Motility   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Brain gut axis; Cortical evoked potentials; CRF; Irritable bowel syndrome; Serotonin; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ACUTE TRYPTOPHAN DEPLETION; ARTICLE; BRAIN GUT AXIS; EVOKED CORTICAL RESPONSE; EVOKED MUSCLE RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE INNERVATION; IRRITABLE COLON; MEDICAL PROCEDURES; MENTAL STRESS; SEROTONINERGIC TRANSMISSION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; EFFERENT NERVE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INNERVATION; PATHOPHYSIOLOGY; REVIEW; SENSORY NERVE;

ANIMALS; BRAIN; EFFERENT PATHWAYS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IRRITABLE BOWEL SYNDROME; PITUITARY-ADRENAL SYSTEM; SEX FACTORS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; VISCERAL AFFERENTS;

EID: 84894625219     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-014-0379-z     Document Type: Article

References (70)

1. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006;36:724-8.
2. Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med. 2001;52:319-38.
3. Pae CU, Masand PS, Ajwani N, et al. Irritable bowel syndrome in psychiatric perspectives: a comprehensive review. Int J Clin Pract. 2007;61:1708-18.
4. Masand PS, Kaplan DS, Gupta S, et al. Irritable bowel syndrome and dysthymia. Is there a relationship? Psychosomatics. 1997;38:63-9.
5. Barbara G, Cremon C, De Giorgio R, et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13(4):308-15.
6. Bouin M, Meunier P, RiberdyPoitras M, Poitras P. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal specific defect or a general systemic condition? Dig Dis Sci. 2001;46:2542-8.
7. Zhou Q, Fillingim RB, Riley JL, et al. Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain. 2010;148:454-61.
8. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994;107:271-93.
9. Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2007;9:378-84.
10. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842-8.
11. Hobday DI, Aziz Q, Thacker N, et al. A study of the cortical processing of ano-rectal sensation using functional MRI. Brain. 2001;124:361-8.
12. Ladabaum U, Minoshima S, Hasler WL, Cross D, et al. Gastric distention correlates with activation of multiple cortical and subcortical regions. Gastroenterology. 2001;120:369-76.
13. Hansen MB. The enteric nervous system I: the organization and classification. Pharmacol Toxicol. 2003;92:105-13.
14. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst. 2000;81:87-96.
15. Langley JN. The autonomic nervous system, part 1. Cambridge: W. Heffer; 1921.
16. Hansen MD. Neurohumoral control of gastrointestinal motility. Physiol Res. 2003;52(1):1-30.
17. Hansen MB. The enteric nervous system II: gastrointestinal functions. Pharmacol Toxicol. 2003;92:249-57.
18. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology. 1998;114:559-78.
19. Gaman A, Kuo B. Neuromodulatory processes of the brain-gut axis. Neuromodulation. 2009;11(4):249-59.
20. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47:861-9.
21. Straub RH, Herfarth H, Falk W, et al. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol. 2002;126:116-25.
22. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-90.
23. Thijssen AY, Jonkers DM, Leue C, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44:e236-41.
24. Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French club of digestive motility. Eur J Gastroenterol Hepatol. 1997;9:345-52.
25. Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990;113:828-33.
26. Ren TH, Wu J, Yew D, et al. Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2007;292:G849-56.
27. Fukudo S, Kanazawa M, Kano M, et al. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome. J Gastroenterol. 2002;37:145-50.
28. Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256-61.
29. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854-66.
30. Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38:225-34.
31. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165-86.
32. Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med. 1999;107:74-80.
33. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400-6.
34. Aggarwal A, Cutts TF, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945-50.
35. Heitkemper M, Jarret M, Cain KC, et al. Autonomic nervous system in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276-84.
36. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev. 1990;15:71-100.
37. Taché Y, Kiank C, Stengel A. A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr Gastroenterol Rep. 2009;11:270-7.
38. Million M, Grigoriadis DE, Sullivan S, et al. A novel watersoluble selective CRF1 receptor antagonist, NBI 35965, blunts stressinduced visceral hyperalgesia and colonic motor function in rats. Brain Res. 2003;985:32-42.
39. Trimble N, Johnson AC, Foster A, Greenwood-van Meerveld B. Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterol Motil. 2007;19:754-60.
40. Lembo T, Plourde V, Shui Z, et al. Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil. 1996;8:9-18.
41. Sagami Y, Shimada Y, Tayama J, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004;53:958-64.
42. Hubbard CS, Labus JS, Bueller J, et al. Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. J Neurosci. 2011;31(35):12491-500.
43. Dukes GE, Mayer EA, Kelleher DL, et al. A randomised, double blind, placebo (PLA) controlled, crossover study to evaluate the efficacy and safety of the corticotrophin releasing factor 1 (CRF1) receptor antagonist (RA) GW876008 in irritable bowel syndrome (IBS) patients. Neurogastroenterol Motil. 2009;21:84. Suppl.
44. Thoua NM, Hobson AR, Dukes GE, et al. The selective CRF-1 receptor antagonist GW876008 attenuates stress induced rectal hypersensitivity in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2009;21:85. Suppl.
45. Drossman DA, Li Z, Andruzzi E, Temple R, et al. U.S. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig Dis Sci. 1993;38:1569-80.
46. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001;120:652-68.
47. Viramontes BE, Camilleri M, McKinzie, et al. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:2671-9.
48. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001;358:2061-8.
49. 11C] methyl-L-tryptophan, positron emission tomography and statistical parametric mapping. Can J Gastroenterol. 2003;17(3):191-6.
50. Naliboff BD, Berman S, Chang L, et al. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology. 2003;124:1738-47.
51. Labus JS, Naliboff BN, Fallon J, et al. Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. NeuroImage. 2008;41:1032-43.
52. Jiang Z, Dinov ID, Labus J, et al. Sex-related differences of cortical thickness in patients with chronic abdominal pain) and correlate with symptom severity in IBS female patients. PLoS ONE. 2013;8(9):e73932.
53. Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22(3):329-39.
54. Labus JS, Mayer EA, Jarcho J, et al. Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women. Gut. 2011;60(9):1196-203.
55. Morgan P, Pickens D, Gautam S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54:601-7.
56. Tillisch K, Labus J, Nam B, et al. Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther. 2012;35(3):360-7.
57. Silverman DH, Munakata JA, Ennes H, et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64-72.
58. Drossman DA, Ringel Y, Vogt BA, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754-61.
59. Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G141-54. This metaanalysis points out the relevance of the several ways of studying patients with IBS accordingly to its pathophysiology, more specifically in regards to visceral hypersensitivity.
60. Ammons WS, Girardot MN, Foreman RD. T2-T5 spinothalamic neurons projecting to medial thalamus with viscerosomatic input. J Neurophysiol. 1985;54:73-89.
61. Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology. 2011;140:91-100. In this meta-analysis, the authors review the different areas that have been reported to be activated or inhibited in IBS patients. IBS have greater engagement of regions associated with emotional arousal and endogenous pain modulation when compared to controls.
62. Larsson MB, Tillisch K, Craig AD, et al. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology. 2012;142:463-72. In this study, 44 IBS female patients were compared with 20 healthy age-paired women. They found that hyper- and normosensitive patients with IBS differ in cerebral responses to rectal distensions, consistent with differences in ascending visceral afferent input.
63. Arebi N, Bullas DC, Dukes GE, et al. Distinct neurophysiological profiles in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1086-93. By using cortical-evoked potentials, this authors showed four different neurophysiological patterns in IBS patients.
64. Chan YK, Herkes GK, Badcock C, et al. Alterations in cerebral potentials evoked by rectal distension in irritable bowel syndrome. Am J Gastroenterol. 2001;96:2413-7.
65. Loening-Baucke V, Read NW, Yamada T. Cerebral evoked potentials after rectal stimulation. Electroencephalogr Clin Neurophysiol. 1991;80:490-5.
66. Sinhamahapatra P, Saha SP, Chowdhury A, et al. Visceral afferent hypersensitivity in irritable bowel syndrome evaluation by cerebral evoked potential after rectal stimulation. Am J Gastroenterol. 2001;96:2150-7.
67. Zuo XL, Li YQ, Huang KM, et al. Alterations in cerebral potentials evoked by rectal distention and drinking ice water in patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:1844-9.
68. Remes-Troche JM, Tantiphlachiva K, Attaluri A, Rao SS, et al. A bi-directional assessment of the human brain-anorectal axis. Neurogastroenterol Motil. 2011;23:240-8. This study provides evidence about the feasibility, reproducibility and normal values for bi-directional assessment of brain-gut axis in healthy subjects. Assessment of the afferent pathway was performed with cortical-evoked potentials and motor-evoked potentials for the efferent pathway using transcranial and translumbosacral magnetic stimulation.
69. Coss-Adame E, Valestin J, Bradley C, et al. Investigation of the afferent anorectal-brain neuromuscular axis in irritable bowel syndrome (IBS) and interstitial cystitis (IC). Neurogastroenterol Motil. 2012;24 Suppl 2:24.
70. Coss-Adame E, Valestin J, Bradley C, et al. Investigation of the efferent spinofugal axis by translumbar and trans-sacral magnetic stimulation in irritable bowel syndrome (IBS) and interstitial cystitis (IC). Neurogastroenterol Motil. 2012;24 Suppl 2:175.